CEACAM8 anticorps (AA 271-349) (Cy7)
Aperçu rapide pour CEACAM8 anticorps (AA 271-349) (Cy7) (ABIN6986430)
Antigène
Voir toutes CEACAM8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 271-349
-
Réactivité croisée
- Humain
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human IRS1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- FCM 1:20-100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- CEACAM8 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 8 (CEACAM8))
-
Autre désignation
- CEAcam8
-
Sujet
- Optional[synonyms]: Carcinoembryonic Antigen CGM6, Carcinoembryonic antigen gene family member 6, Carcinoembryonic Antigen Related Cell Adhesion Molecule 8, CD 66b, CD 67, CD66b antigen, CD67, CD67 antigen, CEACAM 8, CEACAM8, CGM 6, CGM6, NCA 95, NCA95, Nonspecific cross reacting antigen NCA 95, Non-specific -reacting antigen NCA-95, Nonspecific cross reacting antigen NCA95, CEAM8_HUMAN, Carcinoembryonic antigen-related cell adhesion molecule 8, CD66b.
-
ID gène
- 1088
-
UniProt
- P31997
Antigène
-